Chap 1 and 2 Flashcards
Resp. Care Pharmacology
The application of pharmacology to cardio pulm disease and critical care
Drug definition
Any chemical that alters the organisms functions or processes
Drug examples
O2, alcohol, lysergic acid diethylamide (LSD), heparin, epinephrine, and vitamins
Pharmacology
study of drugs (chemicals), including their orgins, properties, and interactions with living organism
Pharmacology subdivided more specialized topics (5)
Pharmacy, Pharmacognosy, Pharmacogenetics, Therapeutics, Toxicology
Pharmacy
Preparing and dispensing of drugs
Pharmacognosy
Identification of sources of drugs, from plants, and animals
Pharmacogenetics
Study of the interrelationship of genetic differences and drug effects
Therapeutics
art of treating disease with drugs
Toxicology
Study of toxic substances and their pharmacologic actions- antidotes and poison control
Drug administration/ Pharmacokinetics/ Pharmacodynamics
Principles of drug action from dose administration to effect and clearance from the body
FDA
Food and Drug administration
FDA steps (naming)
Chemical name, code name, generic name, official name, trade name
Chemical name
name indicating drugs chemical structure
code name
name assigned by manufacture to an experimental chemical that shows potential as a drug
Generic name
name assigned by US adopted name (USAN) council when the chemical appears to have therapeutic use and markets out
Generic name also =
nonproprietary name, in contrast to the brand name
Official name
event experimented drug is fully approved for general use, and is admitted to the US pharmacopicia - National Formulary (USP-NF)
Generic name becomes
official name
Trade name
Brand name, or proprietary name, given by a particular manufacturer
Sources of drug info
USP-NF, PDR, NDC
USP-NF
Book of standards containing info about meds, dietary supplements, and medical devices- official standard for drugs marketed in US (“FDA”)
Physicians’ Desk Reference
(PDR) another source of drug info. provides useful info, including descriptive color charts for drug identification, names of manufacturers, and general drug actions
National Drug Code
(NDC), 3 segment number which serves as a product identifier for drugs
3 sources for drugs
Animal, plant, Mineral
Animal
Thyroid hormone, insuline, pancreatic dornase
Plant
Khellin, atrophine, digitalis, reserpine, volatile oils of eucalyptus, pine , anise
Mineral
Copper sulfate, magnesium sulfate, mineral oil
Approval of drug by FDA (US)
-Identify drug (chemical), Animal studies/ toxicology studies, investicational new drug, New drug application
Identify drug (chemical)
With the potential for useful physiologic effects- exemplified by plant product
animal studies
after chemical is isolated and identified- examines its general effect on the animal and effects on specific organs- liver/ kidney
Toxicology studies
examines mutagenicity, teratogenicity, effect on reproductive fertility, and carcinogenicity
Investigational new drug (IND)
phase 1, 2, 3
Phase 1
Test on healthy individuals (volunteers)- basis for pharmacokinetic desc. of drug= rates of absorption, distribution, metabolism, elimination
Phase 2
Small group with targeted disease
Phase 3
Large, multi-center studies to establish safety and efficiency
What comes after successful IND
New drug application (NDA) is filed with the FDA
NDA
Detailed reporting system for 6 months to track
Orphan drug
drug or biologic product for the diagnosis or treatmetn of a rare disease
Rare
disease that affects fewer than 200,000 persons in US
Prescription
Written order for a drug, along with any specific instructions for compounding, dispensing, and taking the drug- written by physician, ostepath, dentist, veterinarian, and other health care practitioners
Prescription includes
- Pts name and address and date orders written, 2.Rx (superscription) 3. Inscription lists the name and quantity of drug 4. Subscription (directions to pharmacist on how to prepare) 5. Signa- directions to patients 6. Name of prescriber- signature
signa- example
Take 1 p.o QID
Acute respiratory distress syndrome (ARDS)
Respiratory disorder characterized by respiratory insufficiency that may occur as a result of trauma, pneumonia, oxygen toxicity, gram-negative sepsis, and systemic inflammatory response
Aerosolized agents
group of aerosol drugs for pulmonary applications that includes adrenergic, anticholinergic, mucoactive, corticosteroid, antiasthmatic, and antiinfective agents and surfactants instilled directly into the trachea
Airway Resistance (RAW)
Measure of the impedance to ventilation caused by the movement of gas through the airway
Cystic fibrosis (CF)
Inherited disease of the exocrine glands affecting the pancrease, respiratory system, and apocrine glands. Symptoms usually begin in infancy and are characterized by increased electrolytes in the sweat, chronic resp. infection, and pancreatic insufficiency
Agonist
Chemical or drug that binds to a receptor and creates an effect on the body
Antagonist
Chemical or drug that binds to a receptor but does not create an effect on the body; it blocks the receptor site from accepting an agonist
Bioavailability
Amount of drug that reacehs the systemic circulation
Drug administration
method by which a drug is made available to the body
Enternal
Use of the intestine
First pass effect
Initial metabolism in the liver of a drug taken orally before the drug reaches the systemic circulation
Hypersensitivity
Allergic or immune mediated raction to a drug, which can be serious, requiring airway maintenance or ventilatory assistance
Idiosyncratic effect
abnormal or unexpected reaction to a drug, other than an allergic reaction, compared with the predicted effect
Inhalation
Taking a substance, typically in the form of gases, fumes, vapors, mists, aerosols, or dusts, into the body by breathing in
Local Effect
Limited to the area of treatment (e.g. inhaled drug to treat constricted airways)
Lung availability/ total systemic availability ratio (L/T ratio)
Amount of drug that is made available to the lung out of the total available to the body
Parenteral
Administration of a substance in any way other than the intestine, most commonly an injection
Pharmacodynamics
Mechanisms of drug action by which a drug molecule causes its effect in the body
The entire course of action of a drug, from dose to effect, can be understood in three phases:
The drug administration, pharmacokinetic, and pharmacodynamic phases
Drug administration
method by which a drug dose is made available to the body
Drug Administration Phase
Entails the interrelated concepts of drug formulation (e.g. compounding a tablet for particular dissolution properties) and drug deliver (e.g. designing an inhaler to deliver a unit dose)
Two key topics pf the Drug Administration Phase are
drug dosage form and the route of administration
Drug dosage form
the physical state of the drug in association with nondrug components Tablets, capsules, and injectable solutions are common drug dosage forms.
The route of administration is the
portal of entry for the drug into the body, such as oral (enternal), injection, or inhalation
Injectable route (e.g. intravenous route) requires
a liquid solution of a drug
whereas the oral route can accomodate
capsules, tablets or liquid solution
Active ingredient in a dosage formulation
drug
Aerosolized agents for inhalation have ingredients that control rates such as
Preservatives, Propellants for MDI formulations, dispersants (surfactants), and carrier agents for dry powder inhalers (DPIs)
Routes of administration have been divided into five broad categories
Enternal, Parenteral, Transdermal, inhalation, and topical
Enternal
Refers literally to the small intestine, but the enternal route of administration is more broadly applicable to administration of drugs intended for absorption anywhere along the gastrointestinal tract
Most common enteral route is
by mouth (oral) because it is convenient, is painless, and offers flexibility in possible dosage forms of the drug
Systemic effect can be achieved when
the drug is not destroyed or inactivated in the stomach and is absorbed into the bloodstream, distribution throughout the body
Other enteral routes of administration include
suppositories inserted in the rectum, tablets placed under the tongue (sublingual), and drug solutions introduced through an indwelling gastric tube
Parenteral (injectable)
“besides the intestine” which implies any route of administration other than enternal. Commonly refers to injection of a drug.
Most common parenteral
Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), Intrathecal (IT), Intraosseous (IO)
Intravenous (IV)
Injected directly into the vein, allowing nearly instataneous access to systemic circulation.
Intramusclular (IM)
Injected deep into a skeletal muscle.
Subcutaneous (SC)
Injected into the subcutaneous tissue beneath the epidermis and the dermis
Intrathecal (IT)
Injected into the arachnoid membrane of the spinal cord to diffuse throughout the spinal fluid
Intraosseous (IO)
Injected into the marrow of the bone
Transdermal
application to the skin to produce a systemic effect. Advantage of this route is that it can supply long-term continuous delivery to the systemic circulation. The drug is absorbed percutaneously, obviating the need for a hypodermic needle and decreasing the fluctuations in plasma drug levels that can occur with repeated oral administration
Inhalation
given for either a systemic effect or a local effect in the lung.
Two of the most common drug formulations given by inhalation
Gases (anesthesia-systemic effect), and aerosolized agents intended to target the lung or respiratory tract in the treatment of resp. disease (local effect)
Topical
Directly to skin or mucous membranes to produce a local effect. Such drugs are often formulated to minimize systemic absorption- corticosteroid cream to an area of contact dermatitis
Pharmacokinetic Phase
time course and disposition of a drug in the body, based on its absorption, distribution, metabolism, and elimination (describes what the body does to a drug)
Pharmacodynamics
Describes what the drug does to the body
Systemic effect steps, a pill must first
dissolve to liberate the active ingredient. The free drug must then reach to the epithelial lining of the stomach or intestine and traverse the lipid membrane barriers of the gastric and vascular cells before reaching the bloodstream for distribution throughout the body. The lining of the lower resp tract also presents barriers to drug absorption. After transversign these layers, a drug can reach the smooth muscle or glands of the airway
The lining of the lower resp tract also presents barriers to drug absorption. This mucosal barrier consists of five identifiable elements
- Airway surface liquid 2. Epithelial cells 3. Basement membrane 4. interstitium 5. Capillary vascular network
Aqueous diffusion
Occurs in the aqueous compartments of the body, such as the interstitial spaces or within a cell transport across epithelial linings is restricted because of small pore size; capillaries have larger pores, allowing passage of most drug molecules. Diffusion occurs by a concentration gradient
Lipid diffusion is an important mechanism for
drug absorption because of the many epithelial membranes that must be crossed if a drug is to distribute in the body and reach its target organ
Epithelial cells have lipid membranes, and a drug must be what to diffuse across such a membrane
Lipid-soluble (nonionized, nonpolar)
Lipid insoluble drugs tend to be
ionized, or have a positive and negative charges separated on the molecule (polar), and are water- soluble
Carrier-Mediated Transport
Special carrier molecules embedded in the lipid membrane can transport some substances, such as amino acids, sugars, or naturally occurring peptides, and the drugs that resemble these substances.
Pinocytosis
Refers to the incorporation of a substance into a cell by a process of membrane engulfment and transport of the substance within vesicles, allowing translocation across a membrane barrier.
Bioavailability
indicates the proportion of a drug that reaches the systemic circulation. Is influenced not only by absorption but also by inactivation caused by stomach acids and by metabolic degradation, which can occur before the drug reaches the main systemic compartment
Minimal Inhibitory Concentration (MIC)
The lowest concentration of a drug at which a microbial population is inhibited
Drug distribution is
the process by which a drug is transported to its sites of action, is eliminated, or is stored
The plasma concentration of a drug is partially determined by
the rate and extent of absorption versus the rate of elimination for a given dose amount
The volume of the compartment in which the drug is distributed also determines the
concentration achieved in plasma
Volume of distribution (VD)
is the same as the volume of the plasma compartment